tradmap

SRXH SRx Health Solutions, Inc.

$0.97 -3.03%

Data as of close

Consumer Defensive · Beverages

SRx Health Solutions, Inc. (SRXH) is a consumer defensive company in the Beverages industry, with a market capitalization of $20 million. Shares last traded at $0.97, 70.6% below their 52-week high. Net profit margin is -526.4%, below the peer median of 11.1%. Revenue declined 81.3% year over year.

Market Cap
$20M
Shares Out
20.3M
EPS (TTM)
$42.30
P/E (TTM)*
—
P/S Ratio
3.01
P/B Ratio
0.14
Dividend / Share
—
Dividend Yield
—
52-Week High
$3.30
52-Week Low
$0.09
Volume (venue)
6,500
Avg Vol (3m, venue)
18,138.81

* P/E (TTM) = market cap ÷ net income over the trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year — the same basis as the peer table and the screener, so it can differ from price ÷ EPS.

Performance

1W
-7.65%
1M
-39.39%
3M
-28.70%
6M
—
YTD
—
1Y
—

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)
23.43
SMA (50)
$1.47
SMA (200)
$0.77
Price vs SMA50
-34.10%
Price vs SMA200
+26.05%
ATR (14)
$0.09

Full technical analysis (26 indicators, D/W/M) →

Financials

Revenue
$7M
Net Income
-$34M
Gross Margin
-84.7%
Operating Margin
—
Net Margin
-526.4%
Return on Equity
-24.1%
Return on Assets
-23.7%
Current Ratio
27.55
Debt / Equity
0.00
Revenue Growth (YoY)
-81.3%

Trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year; revenue is the fiscal-year figure where quarterly revenue covers under half of it (typical for banks, insurers and REITs), and margins are taken on it; latest reported period ends 2026-06-30. Source: SEC EDGAR/XBRL.

Full financials — revenue, cash flow & debt over time →

Recent earnings

PeriodEPS (diluted)Reported
Q3 2026 -$0.36 2026-08-13
Q2 2026 -$0.02 2026-05-14
Q1 2026 -$0.26 2026-02-13
Q4 2025 (derived) $42.94 2025-12-05
FY 2025 -$2.13 2025-12-05
Q3 2025 -$44.51 2025-09-30

Q4 marked "derived" = fiscal-year EPS minus Q1–Q3 (10-Ks report only the annual figure); EPS is not strictly additive, so it can differ by a cent or two from the issuer's own Q4.

Full earnings history →

Beverages peers

SRXH vs 14 industry peers (Beverages), by market cap. Data as of close

P/S vs peers
3.01 / 2.54 med
+18% premium
Net margin vs peers
-526.4% / 11.1% med
below median
1–14 of 14
KOCoca-Cola$412.5B28.208.0828.7%+1.79%
PEPPepsiCo$191.4B17.571.9511.1%+2.26%
KDPKeurig Dr Pepper$50.3B35.232.507.1%+3.01%
STZConstellation Brands$23.8B12.372.5920.9%+3.98%
BF.BBrown–Forman$13.8B19.113.5218.4%+4.62%
PRMBPrimo Brands Corp$7.5B75.001.121.5%+5.14%
COCOVita Coco Company, Inc.$3.3B27.574.3315.7%-0.54%
WESTWestrock Coffee Co$947M—0.72-4.9%-2.27%
SUJASuja Life, Inc.$247M———-2.54%
BRCCBRC Inc.$152M—0.35-1.5%+0.12%
BUDABUDA JUICE, INC.$93M26.217.3528.0%+3.95%
SRXHSRx Health Solutions, Inc.$20M———-3.03%
WVVIWILLAMETTE VALLEY VINEYARDS INC$9M—0.25-5.9%-1.05%
AMSSAMASS BRANDS$3M———-4.38%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.